Literature DB >> 16173947

Upregulated function of phosphatidylinositol-3-kinase in genetically hypertensive rats: a moderator of arterial hypercontractility.

Carrie A Northcott1, Joel Hayflick, Stephanie W Watts.   

Abstract

1. The growth enzyme phosphatidylinositol 3-kinase (PI3K) was recently implicated in the mediation of arterial spontaneous tone, an event observed in arteries from hypertensive, but not normotensive, subjects that contributes to changes in total peripheral resistance in the hypertensive state. We have shown this occurrence in experimentally induced models of hypertension. However, because the majority of hypertension is genetically based, it is important to demonstrate a similar change in genetically hypertensive animals. 2. Aorta from spontaneously hypertensive rats (SHR; systolic blood pressure = 183 +/- 4 mmHg) and Wistar Kyoto (WKY) rats (115 +/- 2 mmHg) were isolated for the measurement of isometric contractile force. Aorta from SHR displayed small increases (approximately 5% maximum phenylephrine (PE)-induced contraction) in spontaneous tone, whereas aorta from WKY rats displayed none. The non-selective PI3K inhibitor LY294002 (20 micromol/L) and the selective inhibitor of the p110delta catalytic subunit of PI3K IC87114 (20 micromol/L) caused a fall of basal tone in SHR aorta (20 +/- 7 and 24 +/- 6% of the initial PE contraction, respectively), but did not alter tone in arteries from WKY rats. LY294002, but not IC87114, normalized the increased potency of noradrenaline (NA) observed in aorta from SHR (-log EC50 values for NA in the presence of vehicle in WKY rats and SHR 7.5 +/- 0.1 and 7.8 +/- 0.1, respectively (P < 0.05); -log EC(50) values for NA in the presence of LY294002 in WKY rats and SHR 7.0 +/- 0.1 and 7.0 +/- 0.1, respectively). 3. Biochemical expression of the p110 catalytic and p85 regulator subunits of PI3K in western analyses revealed no difference in expression of the regulatory p85alpha or p110alpha protein subunits between WKY rats and SHR; p110gamma was not detected. In contrast, p110delta expression was increased greater than 30% in aorta from SHR compared with WKY rats (827.6 +/- 88.5 vs 576.8 +/- 53.4 arbitrary densitometry units, respectively). Immunohistochemical analyses revealed expression of the p110delta isoform in the smooth muscle of arteries. 4. These data underscore the relevance of an enzyme historically classified as one committed to growth/anti-apoptosis in modifying contractility and supports involvement of PI3K in genetically based hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16173947     DOI: 10.1111/j.1440-1681.2010.04276.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

Review 1.  Phosphoinositide 3-kinase signalling in lung disease: leucocytes and beyond.

Authors:  David A Medina-Tato; Stephen G Ward; Malcolm L Watson
Journal:  Immunology       Date:  2007-08       Impact factor: 7.397

2.  Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness.

Authors:  B Gwen Windham; Michael E Griswold; S Morteza Farasat; Shari M Ling; Olga Carlson; Josephine M Egan; Luigi Ferrucci; Samer S Najjar
Journal:  Am J Hypertens       Date:  2010-02-11       Impact factor: 2.689

3.  Phosphatidylinositol 3-kinase-δ up-regulates L-type Ca2+ currents and increases vascular contractility in a mouse model of type 1 diabetes.

Authors:  J F Pinho; M A A Medeiros; L S A Capettini; B A Rezende; P P Campos; S P Andrade; S F Cortes; J S Cruz; V S Lemos
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

4.  PI(3,4,5)P3 potentiates phospholipase C-beta activity.

Authors:  Yong Zhang; Sun Hyung Kwon; Walter K Vogel; Theresa M Filtz
Journal:  J Recept Signal Transduct Res       Date:  2009       Impact factor: 2.092

5.  Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKCepsilon and PKCdelta, in adult cardiac muscle cells.

Authors:  Phillip C Moschella; Vijay U Rao; Paul J McDermott; Dhandapani Kuppuswamy
Journal:  J Mol Cell Cardiol       Date:  2007-10-04       Impact factor: 5.000

6.  Chronic treatment with LY294002, an inhibitor of phosphatidylinositol 3-kinase, attenuates ischemia/reperfusion-induced cardiac dysfunction in normotensive and hypertensive diabetic animals.

Authors:  Ibrahim F Benter; Ibrahim Al-Rashdan; Jasbir S Juggi; Mariam H M Yousif; Saghir Akhtar
Journal:  Mol Cell Biochem       Date:  2012-11-04       Impact factor: 3.396

7.  Mechanisms of augmented vasoconstriction induced by 5-hydroxytryptamine in aortic rings from spontaneously hypertensive rats.

Authors:  K Budzyn; R M Ravi; A A Miller; C G Sobey
Journal:  Br J Pharmacol       Date:  2008-06-16       Impact factor: 8.739

8.  Regulation of p110delta PI 3-kinase gene expression.

Authors:  Klaartje Kok; Gemma E Nock; Elizabeth A G Verrall; Michael P Mitchell; Daan W Hommes; Maikel P Peppelenbosch; Bart Vanhaesebroeck
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.